Catalyst Wire Dossier Catalyst Wire Dossier

Remaxol

· POLYSAN Scientific & Technological Pharmaceutical Company
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Remaxol, covering 2020-07-10 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: Remaxol® Used in the Treatment of Patients With Gallstone Disease Complicated With Obstructive Jaundice

See pricing